Reports for PENDOPHARM DIVISION OF PHARMASCIENCE INC

Company Name
PENDOPHARM DIVISION OF PHARMASCIENCE INC

Shortage reports

Actual shortage:

3 (2%)

Anticipated shortage:

0 (0%)

Avoided shortage:

5 (4%)

Resolved:

123 (94%)

131

Discontinuation Reports

To be discontinued:

0 (0%)

Discontinued:

2 (67%)

Reversed:

1 (33%)

3

17 (13%)

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SPASMHALT-8 325MG 400MG 8MG TABLET Resolved 2018-02-01 2025-07-30 38087
SPASMHALT-8 325MG 400MG 8MG TABLET Resolved 2017-03-21 2025-07-30 3761
XYLAC 2.5MG TABLET Resolved 2024-02-22 2024-05-10 220293
XYLAC 2.5MG TABLET Resolved 2017-08-15 2017-10-05 19370
XYLAC 2.5MG TABLET Resolved 2017-06-12 2017-10-05 12630
XYLAC 2.5MG TABLET Resolved 2024-07-11 2024-09-23 232696
XYLAC 50MG TABLET Resolved 2017-04-04 2025-07-30 5448
XYLAC 25MG TABLET Resolved 2024-03-19 2024-11-14 222737
XYLAC 25MG TABLET Avoided shortage 2017-07-26 2017-10-05 17288
XYLAC 10MG TABLET Resolved 2024-04-29 2024-11-14 226445
XYLAC 5MG TABLET Resolved 2017-04-04 2025-07-29 5445

Showing 121 to 131 of 131

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
IBAVYR 400MG TABLET Discontinued 2023-01-20 2023-01-20 182029
IBAVYR 200MG TABLET Discontinued 2023-01-20 2023-01-20 182060
OCPHYL 500MCG SOLUTION Reversed 2017-04-10 2017-04-10 6237

Showing 1 to 3 of 3